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Summary No previous controlled studies of ovarian germ cell tumours have been reported; however the
tumour is similar to germ cell testicular cancer in terms of histology, age-specific incidence rates (i.e. highest
rates in young adulthood), and secular trends of increasing incidence. The investigation was designed to
determine if maternal hormonal factors which have been found to increase the risk of testis cancer in male
offspring are also risk factors for the ovarian tumour. The analysis is based on 73 cases diagnosed before age
35 and 138 age-race matched controls. The cases were identified by tumour registries in Los Angeles (1972-84)
and Seattle (1974-84) and controls were selected from friends and/or neighbourhood residents. Interviews
were conducted on the telephone with mothers of cases and controls. The primary finding was that mother's
use of exogenous hormones (including the hormonal pregnancy test, DES or other supportive hormones, and
inadvertant use of oral contraceptives after conception) increased risk (Odds ratio, OR=3.60, 95% CL= 1.2-
13.1). Other maternal factors associated with elevated risk were high pre-pregnancy body mass (OR=2.7,
95% CL= 1.0-7.6), more rapid achievement of regular menstruation after menarche (OR= 1.8, 95%
CL=0.9-3.8), and age at index pregnancy under 20 (OR=2.8, 95% CL=1.0-10.7). In conclusion, these
results support findings from testis cancer studies regarding a hormonal aetiology for germ cell tumours, and
a mechanism by which oestrogen may affect the germ cells is proposed.
Ovarian germ cell cancer is quite rare and no previous
controlled epidemiologic studies have been reported. The
similarity of these tumours to germ cell testicular cancer in
terms of histology (Teilum, 1976), age-specific incidence rates
highest in the young adult age range (Walker et al., 1984;
Weiss, 1982), and secular trends of increasing incidence
(Walker et al., 1984) prompted this investigation to
determine if maternal hormonal factors, which may increase
risk of testis cancer in male offspring (Depue et al., 1983;
Henderson et al., 1979; Schottenfeld et al., 1980), are also
risk factors for ovarian germ cell tumours.
Specifically, this study addressed the effects of in utero
exogenous hormonal (especially oestrogen) exposure (i.e. DES
or other supportive hormones, hormonal pregnancy tests,
and use of oral contraceptives after conception) as well as
maternal factors possibly related to higher endogenous
oestrogen levels [e.g. obesity (Edman & MacDonald, 1978),
nausea (Depue et al., 1981), and parity (Bernstein et al.,
1986)] on risk of germ cell tumour development in female
offspring.
Materials and methods
The cases represented all malignant germ cell tumours of the
ovary diagnosed in women under age 35 between 1972-1984
in Los Angeles County and between 1974-1984 in the Seattle
area. The Los Angeles cases were identified by Cancer
Surveillance Program maintained by the University of
Southern California (Mack, 1977); the Seattle cases were
obtained from the Seattle Tumour Registry maintained by
the Fred Hutchinson Cancer Research Program (US Dept.
of Health and Human Services, 1981). The major histologic
categories under study included (1) dysgerminomas, and (2)
the teratoma group including embryonal carcinomas, im-
mature teratomas, and endodermal sinus tumours. Ten cases
of gonadoblastoma and other germ cell tumours where the
case was known to have abnormal sex chromosomes (e.g.
XY or XO, XY) were excluded (Simpson & Photopulos,
1976). Of 163 eligible cases (129 in Los Angeles and 34 in
Seattle), physician permission to contact the patients was
obtained for 144 (88%).
Since the in utero exposure period was a major focus of
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the study, the primary interview was conducted with the
mother of the case. Of the 144 cases for whom we were able
to obtain physician approval, 33 could not be located and 26
did not have a natural mother who could be interviewed [10
mothers were deceased and others were lost due to senility
(N =4), language problems (N=4), residence out of the
country (N=5), or the case had been adopted (N=3)]. This
left 85 cases (52% of the original case group) who were
located with an available natural mother. Mother interviews
were completed for 74, or 87% of this final group. In total,
59 of the interviewed case mothers were from the Los
Angeles case series and 15 were from Seattle.
For each case an attempt was made to identify two age-
and race-matched controls using friends or neighbours so as
to approximate a socioeconomic match. For cases under age
18 at diagnosis, the controls were selected from friends or
neighbours of the case in the year prior to diagnosis. For
cases over age 18 at diagnosis, controls were selected from
among the case's friends or neighbours at the time of
graduation from high school, in order to approximate the
social class of the case's mother rather than of the case
herself.
The procedure for obtaining the potential friend control
names was to ask the case mother for a list of first names of
friends of the case from the appropriate time period at the
beginning of the interview and to have her rank them
according to closeness in friendship and age to the case.
Then at the end of the interview, permission was requested
to contact these friends, beginning with the first two ranked
friends who were within two years of the case's age and of
the same race.
Neighbourhood controls were sought when two friend
controls could not be identified. The neighbourhood controls
were selected by following a specified walking pattern in the
blocks around the case's residence. Residents of each unit
were surveyed until a race and age (±5 years) match was
located.
Once the control was selected, permission was sought to
interview her mother. At least one control mother interview
was completed for 73 of the 74 cases whose mothers were
interviewed, and two or more were obtained for 54 cases.
For 20 cases, only neighbourhood control mothers were
used, and in 8 cases both friend and neighbourhood control
mothers were used. In total, 138 control mothers were
interviewed, 93 from friends and 45 from neighbourhood
residents. Three potential friend controls and 10 qualifying
neighbourhood controls refused to participate.
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The interviews with the mothers were conducted by
telephone and information was obtained on the mother's
pre-pregnancy weight, use of any drugs, occurrence of
nausea and other health conditions during pregnancy,
outcomes of other pregnancies, mother's health history and
characteristics of menstruation. Information on hormonal
drug exposure of three major types (i.e. oral contraceptive
use, hormonal pregnancy test, and supportive hormones) was
ascertained from four different interview questions, as well
as from medical records. To attempt to verify any reported
drug exposures, or to identify unreported exposures,
permission was sought to obtain both hospital obstetrical
records and physician prenatal records for all case and
control mothers regardless of hormonal drug exposure.
Hospitals were requested to send copies of the mother's
and infant's hospital record and doctors were asked to fill
out a form requesting the mother's use of drugs of any kind
and occurrence of illness during the index pregnancy and in
the year before. Hospital records were more readily available
than the doctor's prenatal notes because hospitals kept
records longer and hospital names were more easily recalled
and were easier to locate than a doctor who may have died,
retired, or sold his practice. However, in general, the hospital
records were less informative regarding the prenatal period
than the doctor's notes. In total, hospital records were
obtained for 82 mothers (36% of the case mothers and 41%
of control mothers); doctor's notes were obtained for 35
mothers (14% of the mothers and 18% of control mothers);
and either a hospital or a doctor's record was obtained for
92 mothers (39% of the mothers and 46% of control
mothers).
Statistical analyses were conducted by calculating Mantel-
Haenszel matched odds ratios with a variable number of
controls per case for dichotomous exposures (Breslow &
Day, 1980), with 95% two-sided approximate confidence
intervals (Miettinen, 1970). Conditional logistic regression
methods were used to test dose response relationships as well
as to control for potential confounding factors [in addition
to the matching variables] (Breslow & Day, 1980).
Results
The 74 cases whose mothers were interviewed were re-
presentative of the total group of eligible cases on the basis
of age and year of diagnosis, birth year, histology type, and
mortality status. In Los Angeles, the completed cases were
significantly less likely to have been born in a Latin country
than the total group of eligible cases (0% vs. 12%); to reside
in the lower socio-economic status tracts (5% vs. 12%); and
to have been of White Hispanic origin (15% vs. 30%).
Among the 73 cases for whom controls were obtained, 20
were under age 15 at diagnosis and 53 were between ages 15
and 34. By race, 54 were White non-Hispanic, 8 were White
Hispanic, 7 were Black, and 4 were Asian. By histology
group, 34 of the cases were dysgerminomas and 39 were in
the teratoma group.
The results presented pertain to two major areas of inves-
tigation: (1) factors related to the in utero environment; and
(2) other maternal factors suggestive of hormonal
abnormalities. All odds ratios reported are based on a
matched analysis.
A. In utero period
Specific types of reported hormonal drug usage and sources
of information are summarized in Table I. Based on the
mother's information alone, 9 case mothers and 8 control
mothers reported exposure to oestrogenic hormones during
the first trimester of pregnancy for a matched OR of 2.8
(95% CL = 1.0, 7.9). Use of the nedical records akered some
of the exposures for specific irivid-wals, but the resulting
ORl remained elevated [OR based on mothers' reports plus
medical record information=3.6 (95% CL= 1.2-13.1)]
(Table II). Specifically, three exposures (2 for case mothers
and 1 for a control mother) were not reported by the
mothers and were identified only from medical records. In
addition, use of medical records also eliminated one case
mother and one control mother from the exposed category.
The case mother reported taking DES, but review of her
records and correspondence with her physician indicated that
she was prescribed stilboestrol only to dry up her breasts
after pregnancy. The control mother also reported receiving
DES but medical records showed that her exposure began
after the first trimester of pregnancy.
After applying the medical record information to the
mother's initial reports, 3 case and 2 control mothers were
classified as having received hormonal pregnancy tests, 2
case and 2 control mothers used oral contraceptives or were
taking oestrogen to regulate periods at the time of
conception, and 5 case and 4 control mothers received some
supportive hormonal therapy during the first trimester. The
OR for hormonal drug exposure used throughout the paper
is based on the mothers' reports with the medical record
information since records were sought uniformly for all case
and control mothers. None of the ORs for non-hormonal
types of drugs used during pregnancy was elevated, with the
exception of aspirin.
Little change in the OR for hormonal drug use resulted
after controlling for the potential confounding effect of an
abnormal pregnancy pattern of the mother (i.e. either
bleeding during the index pregnancy or a previous
miscarriage) (adjusted OR=3.5, 95% CL= 1.2-10.8).
Pre-pregnancy body mass was measured by the Quetelets
Index (QI) (weight (kg)/height [m2]). Because we were
especially interested in the extreme of body mass the QI was
grouped into four categories with the upper group re-
presenting the top decile of the distribution. No dose
response relationship was apparent (Table II); however, the
OR for the upper group as compared to the lowest group
was elevated (OR=2.5, 95% CL=0.9-7.1). When the index
was dichotomized, with this upper group representing the
exposed, the OR was 2.7 (1.0-7.6).
Nausea (defined as having morning sickness or feeling
nauseous) was analyzed as a dichotomous exposure with
exposed individuals defined as those who had experienced
nausea in the first trimester and in combination with either
use of prescription drugs or limitation of daily activity. The
ORs for nausea alone (0.8, 95% CL=0.5-1.5), or in
combination with either use of prescription drugs (1.0, 95%
CL=0.4-2.8) or limitation of activities (0.8, 95% CL=0.4-
2.0) were all close to 1.0. The OR for nausea when the index
pregnancy was the first pregnancy also was not elevated (0.6,
95% CL=0.3-1.4).
B. Other maternalfactors
We evaluated several other maternal health characteristics as
possible indices of an underlying abnormal oestrogenic
milieu. Matched ORs were elevated for a history of an
ovarian cyst (1.3, 95% CL=0.6-4.3), hysterectomy due to
fibroid or unspecified uterine tumours (1.3, 95% CL=0.5-
2.9), and personal history of breast cancer (2.5, 95%
CL=0.4-24.9) (Table III). Other maternal factors had odds
ratios of less than one including thyroid problems (0.8, 95%
CL=0.3-1.4) a history of cancer of any type, (0.7, 95%
CL=0.2-2.0), a history of cervical cancer (0.3, 95%
CL=0.4-1.2), and hysterectomy due to reasons other than
uterine tumours (0.6, 95% CL=0.2-1.0). Little difference in
age at menarche was observed between case and control
mothers; however, case mothers achieved regular menstrual
periods more rapidly. The matched OR for establishing
regular periods within three months of menarche (vs. taking
longer) was 1.8 (95% CL=0.9-3.8).
The case and control mothers were very similar to each
other with regard to mean age at first pregnancy (21.8 for420 A. H. WALKER et al.
Table I Description of hormonal drug use as reported by mothers and medical records review
Yr. of Drug Mother's Record
birth used description review
DES Had had previous miscarriage
and was taking DES to prevent
miscarriage.
Oestrogen Taking oestrogen to regulate
periods at time of conception.
DES Had vaginal bleeding in 3rd
month and doctor prescribed
pills.
DES Had vaginal bleeding and
medication was prescribed.
Hexesterol No use described.
DES
Hormonal Preg.
Test
DES
Took stilboestrol to prevent
miscarriage.
Received injection for pregnancy
test.
Hospital records obtained,
but did not cover 1st
trimester.
No records obtained.
No records obtained.
No records obtained.
Drs records indicate extensive
use early in pregnancy.
Drs records indicate
stilboestrol use only after
delivery.
No records obtained.
Received injection to protect Hospital records obtained but
pregnancy at 2 weeks gestation. did not cover 1st trimester.
Hormonal Preg. No use described.
Test
Hormonal Preg. Was given 'some' drug to start
test her period
OCs Was not trying to get pregnant
and had been taking birth
control pills for 6yrs.
DES or Had threatened miscarriage in
oestrogen 3rd month and was given
oestrogen.
DES Dr prescribed 13 pills/day and
nurse told her they included
DES.
DES
1958a DES
1963a Hormonal
Test
1965a OCs
Took DES
Took pills for vaginal bleeding
at 3 months.
Preg. GEST test
Took low dose Ortho Novum
and thyroid medicine to get
pregnant and stopped when she
was 2 weeks pregnant.
1966a Hormonal Preg. Had hormonal preg. test in 2nd
Test month.
1969a DES
1969a OCs
Drs records state that she
took Ortho Novum 10mg for
4 days as pregnancy test.
Hospital records obtained but
did nor cover 1st trimester.
Drs records obtained but no
indication of when pill use
ended.
Hospital records obtained but
did nor cover 1st trimester.
No records obtained.
Drs records show DES use
began in 4th month.
Hospital records indicate
history of spotting in early
pregnancy.
Drs records confirmed.
No records obtained.
No records obtained
No use described, but surgery in Hospital records of surgery
early pregnancy reported. indicated stilboestrol use.
Took birth control pills and Hospital records obtained but
didn't stop until 60 days into did not cover 1st trimester.
pregnancy.
aUsed in calculation ofmatched odds ratio for maternal hormonal drug exposure in Table II.
case mothers vs. 22.6 for control mothers) and mean age at
index pregnancy (26.4 for case mothers vs. 26.6 for control
mothers); however, an increased risk of a germ cell tumour
in offspring was observed for mothers who were pregnant
with the index child before the age of 20 (OR =2.8, 95%
CL=1.0-10.7). Somewhat elevated ORs were observed for
ever having had a miscarriage (1.4, 95% CL=0.8-2.8) or
induced abortion (1.4, 95% CL=0.5-2.9). In contrast to a
suggestion from a case series study of germ cell tumours
(Birch et al., 1982), no difference between case and control
mothers was found for ever having had a stillbirth (OR= 1.0,
95% CL=0.2-3.4), and the OR for having a child with a
birth defect (including the index pregnancy) was slightly less
than one (OR=0.8, 95%, CL=0.4-1.4).
Four potential material risk factors for germ cell tumours
of the ovary identified from this study were evaluated in
multivariate analysis: hormonal drug use in pregnancy; high
pre-pregnancy body mass; early age at index pregnancy; and
rapid establishment of regular menstruation after menarche.
Very littIe change occurred in the matched ORs from those
observed in the univariate analyses,
Discussion
The major finding in this study was the elevated risk of an
ovarian germ cell tumour in female offspring following
maternal exposure to hormonal drugs during the index
Cases
1949a
195la
1952a
1953a
1954a
1956
1961a
1963a
1968a
1968a
1972a
Controls
1946a
1954a
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Table II Matched odds ratios (OR) for factors
utero period and ovarian germ cell cancer i
Exposure
category
No. exposed
Cases Controls
N= 73 N=138
A. Drug exposures during pregnancy
Hormonal drugs 10
in 1st trim.
Sleeping pills 1
Diet pills 1
Antibiotics 3
Aspirin 25
Antihistamines 7
Thyroid medicine 4
Diuretics 4
Other medicine 6
7
5
7
43
12
10
11
8
B. Factors related to maternal endogenous
1. Pre-pregnancy bod
_19
> 19-21
>21-25
>25
> 25 (vs. 25)
2. Nausea
In first trimester
Treated by drugs
With limitation
of activity
When index preg.
was first preg.
ly mass (kgm-2)
19
26
14
12
12
39
8
10
hormc
44
46
35
10
10
79
15
21
10 27
Table III Matched ORs for maternal history and
tumour in offspring
No. exposed
Exposure Cases Controls
category N= 73 N=138
A. Medical history
Diabetes 5 6
Thyroid problem 15 37
Cancer, any type 5 12
Breast 2 2
Cervix 1 6
Ovarian cyst 12 15
Hyst. due to 12 19
fibroid tumour
Hyst. due to 10 31
other reason
B. Menstrual and reproductive history
No. of months from
menarche until
regulation menstruation
.3 mos. 48 80
3-12 mos. 12 24
12+mos. 7 28
.3 mos. 48 80
(vs.>3 mos)
Age at index
pregnancy
20-29 36 86
<19 11 9
>29 26 43
.19 11 9
(vs.>19)
Adverse outcomes of
pregnancies
Ever had a:
Stillbirth 3 6
Miscarriage 26 36
Induced abort. 9 14
Child with birth 14 32
defect (including
index child)
related to the in pregnancy. This finding supports results from three of four
in offspring recent epidemiologic studies of risk factors for testicular
germ cell cancer (Depue et al., 1983; Henderson et al., 1979;
Schottenfeld et al., 1980; Moss et al., 1986) (Table IV).
Matched We have previously suggested a possible mechanism to
OR 95% CL explain these observations for cell testicular cancer
(Henderson et al., 1983). We have proposed that risk of
3.6 (1.2-13.1) germ cell tumours of the testis is determined by in utero
0.3 (0.0-1.0)
exposure to high levels of oestrogens, from either
0.4 (0.0-1.8) endogenous or exogenous sources, which interrupts the
0.7 (0.2-2.5) progression from primitive to mature germ cells. We pro-
1.2 (0.7-2.3) posed that these affected germ cells then persist into the
1.0 (0.4-3.0) pubertal period, at which time they multiply under
0.8 (0.3-2.6) stimulation by gonadotropins and give rise to germ cell
0.6 (0.2-1.8) tumours of a variety of histological types.
1.0 (0.4-3.4) Support for this 'arrested development' hypothesis is
nal levels found in karyotype studies of human germ cell tumours
which have indicated that these tumours arise from germ
1.0 Referent cells in which the normal meiotic process has been inter-
1.2 (0.6-2.4) rupted (Linder et al., 1975; Wang et al., 1981). In two
0.8 (0.3-1.8) studies of benign ovarian teratomas, the high proportion
2.5 (0.9-7.1) with homozygous or nearly homozygous chromosomes
2.7 (1.0-7.6) suggests that the tumours occurred in germ cells in which
0.8 (0.4-1.5) meiosis II was supressed (Linder et al., 1975). In contrast,
1.0 (0.4-2.8) male testicular teratomas have shown heterozygosity in
0.8 (0.4-2.0) enzyme markers, centromeres, and possession of the Y
chromosome (Wang et al., 1981). This could occur if
0.6 (0.3-1.4) meiosis I were suppressed. This would be a logical difference
between the male and female tumours with a hypothesized
prenatal exposure.
A mechanism for how oestrogen exposure may affect the
meiotic process in female germ cells is indicated in studies of
mice which were exposed prenatally to ethinyl oestradiol
ovarian germ cell (Yasuda et al., 1977; Yasuda et al., 1985). A reduced number
of follicular cells and normal primordial follicles as well as
an increased number of degenerating follicles were found in
Matched the ovaries of mice whose mothers were treated on days 11-
OR 95% CL 17 of gestation. The lack of surrounding follicular cells causes an oocyte to prematurely progress through meiosis I
and then usually degenerate (Ohno & Smith et al., 1964).
1.4 (0.5-6.6) The mechanism for the development of the germ cell tumour
0.8 (0.3-1.4)
may be that some of the follicles which are deficient in
2.5 (0.4-24.9) surrounding cells do not degenerate, become
0.3 (0.0-1.2) parthenogenically activated at the completion of meiosis I,
1.3 (0.6-4.3) and persist into adolescent life. In fact, female mice with
1.3 (0.5-2.9) granulosa cell deficient follicles have an increased
susceptibility to teratoma development (Eppig, 1978).
0.6 (0.2-1.0) That the underlying hormonal status of the mother is a
determinant of germ cell tumour risk in offspring receives
some additional limited support from several observations in
this study. Case mothers reported more frequent histories of
1.0 (Referent)
case-control studies examining
the
.09 (0.4R2.0) association between maternal hormone use and testicular germ cell
n (n 2) cancer in offspring v.*tkV. X-V. Y
1.8 (0.9-3.8)
1.0 (Referent)
3.4 (1.1-10.5))
1.4 (0.8-2.5)
2.8 (1.0-10.7)
1.0 (0.2-3.4)
1.4 (0.8-2.8)
1.4 (0.5-2.9)
0.8 (0.4-1.4)
Neighbour-
hood/peer
Study Cases controls OR 95% CL
Henderson (1979)
Exposed 6 1
Not exposed 72 77 5.0a (0.465 O)b
Schottenfeld (1980)
Exposed 11 3 2.8c (0.9-10.3)
Not exposed 179 138
Depue (1983)
Exposed 9 2
Not exposed 88 103 8.0 (1.3-49.0)
Moss (1986)
Exposed 9 10 0.9 (0.3-2.6)
Not exposed 202 204
aMatched; bConfidence limit determined from reported P value
[P(1) =0.11]; CRefers to use of DES or other hormones to control
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ovarian cysts, uterine fibroids and breast cancer. Further-
more, case mothers tended to establish regular menstruation
rapidly and to have their index pregnancy at a young age.
Finally, the elevated risk for an extreme pre-pregnancy body
mass index may support this hypothesis. Obese women have
high bioavailable oestrogen levels, due to increased
aromatization of androstenedione to oestrogen in peripheral
adipose tissue (Edman & MacDonald, 1978), and also due to
lesser amounts of sex-hormone-binding globulin (O'dea et
al., 1979). Among premenopausal women, measurably high
oestrogen levels are apparent only when a women's weight is
at least 20% above that which is normal for her height
(Edman & MacDonald, 1978).
Based on our previous studies of testis cancer (Depue et
al., 1983; Henderson et al., 1979), we had expected that
severe maternal nausea during the index pregnancy would
also be a risk factor for ovarian germ cell tumours,
especially in connection with first pregnancy. Despite the use
of numerous indices to classify severe nausea, no increase in
risk was apparent.
We have considered possible methodologic explanations
for our results. Selection bias might have occurred if case
mothers who used hormonal drugs during pregnancy were
more likely to respond than those who did not. We
minimized possible bias by recruitment of cases into the
study without mention of any study hypotheses, and through
identification of potential friend controls prior to completion
of the interview. The major reasons for noncompletion were
largely due to inability to establish contact in the first place
and not due to refusal to participate based on factors that
could be systematically related to exposures under study.
Interviewed cases were less likely than non-interviewed cases
to be of Hispanic origin and to be of low socioeconomic
status (SES); but controls were selected to be of comparable
ethnicity and social class as the cases.
The long time period between the index pregnancy and the
interview would make totally accurate recall of exposures
equally difficult for both case and control mothers. This
would result in the ORs being biased toward the null. The
use of medical records and directed questions with
appropriate probes was designed to minimize the possibility
of biased recall with case mothers being more likely to report
specific exposures than controls. The specificity of our
finding, i.e. the comparatively low odds ratios observed for
use of non-hormonal drugs, suggests that the elevated odds
ratio observed for hormonal drug use was not the result of
recall bias.
Potential confounders were considered both by matching
and in the analysis of the data. Based on income and
education rankings, control mothers tended to be of
somewhat higher SES than case mothers. If anything, we
expect this residual confounding to bias the odds ratio for
hormonal drug use towards the null, because higher SES is
associated with germ cell tumours of the testis and is also
presumably related to increased access to hormonal drug
use. The major additional potential confounder considered
for hormonal drug use was a previous or current abnormal
pregnancy problem, and adjustment for it resulted in little
change in the OR for hormonal drug use.
We conclude the in utero exogenous hormone exposure in
the first trimester of pregnancy is associated with an
increased risk of ovarian germ cell tumours in adolescence.
Exposure to DES and the hormonal pregnancy test have
been eliminated from current medical practice. Although the
absolute risk to offspring is very low, additional cases of
ovarian germ cell tumours may occur due to continued
inadvertent exposure to oral contraceptives after conception.
Further research on the variation in endogenous hormonal
levels among women in early pregnancy may help in
identifying other potential risk factors.
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